InsidersTradesSigma
博拓生物 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 博拓生物 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 博拓生物 has published 4 reports. Market capitalisation: €5.6bn. The latest transaction was filed on 8 May 2025 (Sale). Among the most active insiders: 高红梅. Every trade is openly available.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
4 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 12,785 of 25,571 companies
51.8
score / 100
Value37
Quality67
FCF yld-0.5%
Earn yld1.0%
EV/EBITDA·
ROE1.2%
Gross mgn46%
Net mgn11%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 May 2025
Declarations4 total
4 of 4 declarations